Biologics Hospitals Bioventus Receives US FDA Approval for DUROLANE® byJosh SandbergSeptember 5, 2017
Biologics Top Stories FIDIA PHARMA USA Inc. Continues to Expand U.S. Presence as Fidia Farmaceutici S.p.A. Leads European Orthopedic Biomaterials Market byJosh SandbergJuly 12, 2017
Hospitals Top Stories FDA Clears Iovera Cold Treatment Device for Knee OA Pain byJosh SandbergMay 19, 2017
Extremities Top Stories Knee osteoarthritis: Steroid injections offer no benefit, study suggests byJosh SandbergMay 17, 2017
Extremities Centrexion Therapeutics to Present Data on CNTX-4975 from the Treatment of Knee Osteoarthritis Pain at IX SIMPAR-ISURA byJosh SandbergMarch 23, 2017
Extremities Hyaluronic injections may delay time to arthroplasty in elderly patients with knee OA byJosh SandbergNovember 30, 2015
Extremities Chondroitin sulfate superior to celecoxib for cartilage loss reduction in patients with knee OA byJosh SandbergNovember 9, 2015
Biologics Sports Medicine Biologic Treatments for OA: A Sports Medicine Perspective byJosh SandbergJuly 20, 2015
Extremities Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Completes Enrollment in US Phase IIb Osteoarthritis Trial byJosh SandbergJune 15, 2015
Recon Cellular Biomedicine Group Announces Publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis byJosh SandbergJune 13, 2015
